Shaolin Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Shaolin Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-889,787	Closed	-$9.28M	–	1031
2023 Q1	$9.28M	Buy	889,787 +189,787	+27%	+$1.96M	0.28%	52
2022 Q4	$7.13M	Hold	700,000	–	–	0.21%	138
2022 Q3	$7.02M	Buy	700,000 +350,000	+100%	+$3.51M	0.19%	160
2022 Q2	$3.49M	Hold	350,000	–	–	0.08%	298
2022 Q1	$3.49M	Buy	+350,000	New	+$3.47M	0.09%	297

Shaolin Capital Management's LVAC Position: Q2 2023 in Review

Shaolin Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 889,787 shares — an estimated $9.28M sold.

Shaolin Capital Management first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $9.28M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Shaolin Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Shaolin Capital Management sold 889,787 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $9.28M.
Shaolin Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Shaolin Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $9.28M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Shaolin Capital Management's 13F filing for Q2 2023, filed 15 Aug 2023.